Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury | MicrobiomeTrials← Back to trialsNCT04633889
Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2021-04-13Est. Completion: 2024-08-26
Enrollment target: 320 participants Locations- Massachusetts General Hospital, Boston, Massachusetts, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Older AdultsHip Fracture SurgeryFascia Iliaca BlockLiposomal BupivacainePostoperative Pain
Older patients with hip fractures often suffer from severe pain. Inadequate analgesia increases the risk of postoperativ…
Beijing, ChinaEst. completion Jun 2028
Metabolic AcidosisAcute Kidney Injury
Severe metabolic acidemia in the critically ill (pH equal or less than 7.20; PaCO2 equal or less than 45mmHg and bicarbo…
Montpellier, FranceCompleted Dec 19, 2023
Acute Kidney Injury
This study aims to investigate shorter vs. standard filter lifespans in critically ill patients receiving continuous ren…
Münster, GermanyEst. completion Jun 2028